120 related articles for article (PubMed ID: 1382052)
1. Functional analysis of novel selective mutants of the reverse transcriptase of human immunodeficiency virus type 1.
Hizi A; Shaharabany M
J Biol Chem; 1992 Sep; 267(26):18255-8. PubMed ID: 1382052
[TBL] [Abstract][Full Text] [Related]
2. The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1.
Loya S; Tal R; Hughes SH; Hizi A
J Biol Chem; 1992 Jul; 267(20):13879-83. PubMed ID: 1378433
[TBL] [Abstract][Full Text] [Related]
3. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
Hizi A; Shaharabany M; Tal R; Hughes SH
J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
Hizi A; Tal R; Hughes SH
Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
[TBL] [Abstract][Full Text] [Related]
5. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities.
Post K; Guo J; Kalman E; Uchida T; Crouch RJ; Levin JG
Biochemistry; 1993 Jun; 32(21):5508-17. PubMed ID: 7684924
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.
Hizi A; Hughes SH; Shaharabany M
Virology; 1990 Apr; 175(2):575-80. PubMed ID: 1691564
[TBL] [Abstract][Full Text] [Related]
7. The DNA-dependent and RNA-dependent DNA polymerase activities of the reverse transcriptases of human immunodeficiency viruses types 1 and 2.
Shaharabany M; Hizi A
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):883-8. PubMed ID: 1722105
[TBL] [Abstract][Full Text] [Related]
8. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Shaharabany M; Hizi A
J Biol Chem; 1992 Feb; 267(6):3674-8. PubMed ID: 1371274
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis of cysteine 280 of the reverse transcriptase of human immunodeficiency virus type-1: the effects on the ribonuclease H activity.
Sevilya Z; Loya S; Duvshani A; Adir N; Hizi A
J Mol Biol; 2003 Mar; 327(1):19-30. PubMed ID: 12614605
[TBL] [Abstract][Full Text] [Related]
10. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
Sevilya Z; Loya S; Adir N; Hizi A
Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
[TBL] [Abstract][Full Text] [Related]
11. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity.
Tisdale M; Schulze T; Larder BA; Moelling K
J Gen Virol; 1991 Jan; 72 ( Pt 1)():59-66. PubMed ID: 1703563
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the RNA- and DNA-dependent DNA polymerase activities of point mutants of HIV-1 reverse transcriptase lacking ribonuclease H activity.
Dudding LR; Nkabinde NC; Mizrahi V
Biochemistry; 1991 Oct; 30(43):10498-506. PubMed ID: 1718422
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
14. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Hizi A; Tal R; Shaharabany M; Loya S
J Biol Chem; 1991 Apr; 266(10):6230-9. PubMed ID: 1706712
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase.
Boyer PL; Ferris AL; Clark P; Whitmer J; Frank P; Tantillo C; Arnold E; Hughes SH
J Mol Biol; 1994 Oct; 243(3):472-83. PubMed ID: 7525967
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of the conserved aspartic acid 443, glutamic acid 478, asparagine 494, and aspartic acid 498 residues in the ribonuclease H domain of p66/p51 human immunodeficiency virus type I reverse transcriptase. Expression and biochemical analysis.
Mizrahi V; Brooksbank RL; Nkabinde NC
J Biol Chem; 1994 Jul; 269(30):19245-9. PubMed ID: 7518454
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
18. Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.
Blain SW; Goff SP
J Biol Chem; 1993 Nov; 268(31):23585-92. PubMed ID: 7693692
[TBL] [Abstract][Full Text] [Related]
19. Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
Ben-Artzi H; Zeelon E; Gorecki M; Panet A
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):927-31. PubMed ID: 1371014
[TBL] [Abstract][Full Text] [Related]
20. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase.
Le Grice SF; Naas T; Wohlgensinger B; Schatz O
EMBO J; 1991 Dec; 10(12):3905-11. PubMed ID: 1718745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
